Gene · 79679
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel T-cell signature based on cell pair algorithm predicts survival and immunotherapy response for patients with bladder urothelial carcinoma. | Front Immunol | 2022 | 36466869 | PubTator, text mining | PubMed |
| The effect of neoadjuvant chemotherapy on the tumor immune microenvironment in gastrointestinal tumors. | Front Oncol | 2022 | 36439457 | PubTator, text mining | PubMed |
| Integration of local and systemic immunity in ovarian cancer: Implications for immunotherapy. | Front Immunol | 2022 | 36439144 | PubTator, text mining | PubMed |
| A pyroptosis expression pattern score predicts prognosis and immune microenvironment of lung squamous cell carcinoma. | Front Genet | 2022 | 36437960 | PubTator, text mining | PubMed |
| Ovarian cancer stem cells: Critical roles in anti-tumor immunity. | Front Genet | 2022 | 36437919 | PubTator, text mining | PubMed |
| A Novel Immune-Related Gene Prognostic Index (IRGPI) in Pancreatic Adenocarcinoma (PAAD) and Its Implications in the Tumor Microenvironment. | Cancers (Basel) | 2022 | 36428747 | PubTator, text mining | PubMed |
| Obesity Influences the Expression of Key Immunomodulators in Normal Human Breast Tissue, Basal-like Breast Cancer Patients, and Cell Lines. | Cancers (Basel) | 2022 | 36428692 | PubTator, text mining | PubMed |
| Diagnostic and Prognostic Biomarkers in Renal Clear Cell Carcinoma. | Biomedicines | 2022 | 36428521 | PubTator, text mining | PubMed |
| Latest updates on cellular and molecular biomarkers of gliomas. | Front Oncol | 2022 | 36425564 | PubTator, text mining | PubMed |
| Structuring and validating a prognostic model for low-grade gliomas based on the genes for plasma membrane tension. | Front Neurol | 2022 | 36408514 | PubTator, text mining | PubMed |
| Immune Editing: Overcoming Immune Barriers in Stem Cell Transplantation. | Curr Stem Cell Rep | 2022 | 36406259 | PubTator, text mining | PubMed |
| A panel of seven immune-related genes can serve as a good predictive biomarker for cervical squamous cell carcinoma. | Front Genet | 2022 | 36406134 | PubTator, text mining | PubMed |
| A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer. | Front Immunol | 2022 | 36405735 | PubTator, text mining | PubMed |
| Genomic landscape of the immunogenicity regulation in skin melanomas with diverse tumor mutation burden. | Front Immunol | 2022 | 36389735 | PubTator, text mining | PubMed |
| The Cuproptosis-Related Long Noncoding RNA Signature Predicts Prognosis and Tumour Immune Analysis in Osteosarcoma. | Comput Math Methods Med | 2022 | 36388161 | PubTator, text mining | PubMed |
| Comprehensive analysis of chemokines family and related regulatory ceRNA network in lung adenocarcinoma. | Heliyon | 2022 | 36387469 | PubTator, text mining | PubMed |
| A novel signature based on pyroptosis-related genes for predicting prognosis and treatment response in prostate cancer patients. | Front Genet | 2022 | 36386841 | PubTator, text mining | PubMed |
| Computational recognition of LncRNA signatures in tumor-associated neutrophils could have implications for immunotherapy and prognostic outcome of non-small cell lung cancer. | Front Genet | 2022 | 36386809 | PubTator, text mining | PubMed |
| Drug discovery in China: A snapshot of recent progress. | Acta Pharm Sin B | 2022 | 36386469 | PubTator, text mining | PubMed |
| B7-H4 Polymorphism Influences the Prevalence of Diabetes Mellitus and Pro-Atherogenic Dyslipidemia in Patients with Psoriasis. | J Clin Med | 2022 | 36362461 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/papers?page=31